Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: A review

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 14, 2014, Pages 5501-5508

  Pandurangan, Ashok Kumar ^a   Esa, Norhaizan Mohd ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Colon cancer; Luteolin; Nrf2; Wnt catenin

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA CATENIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LUTEOLIN; NFE2L2 PROTEIN, HUMAN; NOS2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR NRF2; WNT PROTEIN;

APOPTOSIS; BIOSYNTHESIS; CHEMOPROPHYLAXIS; COLORECTAL NEOPLASMS; DRUG EFFECTS; HUMAN; METABOLISM; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; WNT SIGNALING PATHWAY;

ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; BETA CATENIN; CHEMOPREVENTION; COLORECTAL NEOPLASMS; HUMANS; LUTEOLIN; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PRECANCEROUS CONDITIONS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84905976525     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.14.5501     Document Type: Short Survey

References (113)

1. Acebedo AR, Amor EC, Jacinto SD (2014). Apoptosis-inducing activity of HPLC fraction from Voacanga globosa (Blanco) merr. on the human colon carcinoma cell. Asian Pac J Cancer Prev, 15, 617-22.
2. Ahn B, Ohshima H (2001). Suppression of intestinal polyposis in Apc(Min/+) mice by inhibiting nitric oxide production. Cancer Res, 61, 8357-60.
3. Ansil PN, Prabha SP, Nitha A, et al. (2013). Chemopreventive effect of Amorphophallus campanulatus (Roxb.) blume tuber against aberrant crypt foci and cell proliferation in 1, 2-dimethylhydrazine induced colon carcinogenesis. Asian Pac J Cancer Prev, 14, 5331-9.
4. Ashokkumar P, Sudhandiran G (2011). Luteolin inhibits cell proliferation during azoxymethane-induced experimental colon carcinogenesis via Wnt/β-catenin pathway. Invest New Drugs, 29, 273-84.
5. Ashokkumar P, Sudhandiran P (2008). Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis. Biomed Pharm, 62, 590-7.
6. Attoub S, Hassan AH, Vanhoecke B, et al. (2011). Inhibition of cell survival, invasion, tumor growth and histone deacetylase activity by the dietary flavonoid luteolin in human epithelioid cancer cells. Eur J Pharmacol, 651, 18-25.
7. Banerjee N, Kim H, Talcott S, et al. (2013). Pomegranate polyphenolics suppressed azoxymethane-induced colorectal aberrant crypt foci (ACF) and inflammation: possible role of miR-126/VCAM-1 and miR-126/PI3K/AKT/mTOR. Carcinogenesis, 34, 2814-22.
8. Baserga R, Hongo A, Rubini M, et al. (1997). The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta, 1332, 105-26.
9. Baskar A, Ignacimuthu S, Micheal GP, et al. (2011). Cancer chemopreventive potential of luteolin-7-O-glucoside isolated from ophiorrhizamungos linn. Nutri Cancer, 63, 130-8.
10. Bird RP (1995). Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett, 93, 55-71.
11. Bird RP, Good CK (2000). The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett, 112-113, 395-402.
12. Chan JY, Kwong M (2000). Impaired expression of glutathione synthetic enzyme genesin mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta, 1517, 19-26.
13. Chan TS, Galati G, Pannala AS, et al. (2003). Simultaneous detection of the antioxidant and pro-oxidant activity of dietary polyphenolics in a peroxidase system. Free Rad Res, 37, 787-94.
14. Chian S, Li YY, Wang XJ, Tang XW (2014). Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the nrf2 pathway. Asian Pac J Cancer Prev, 15, 2911-6.
15. Chihara T, Shimpo K, Kaneko T, Beppu H (2010). Inhibition of 1, 2-dimethylhydrazine-induced mucin-depleted foci and O6-methylguanine DNA adducts in the rat colorectum by boiled garlic powder. Asian Pac J Cancer Prev, 11, 1301-4.
16. Chiou YS, Ma NJ, Sang S, et al. (2012). Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently suppresses dextran sulfate sodium-induced colitis and colon tumorigenesis in mice. J Agri Food Chem, 60, 3441-51.
17. Choi EM (2007). Modulatory effects of luteolin on osteoblastic function and inflammatory mediators in osteoblastic MC3T3-E1 cells. Cell Biol Int, 31, 870-77.
18. deLau W, Barker N, Clevers H (2007). WNT signaling in the normal intestine and colorectal cancer. Front Biosci, 12, 471-91.
19. Fernándes-Alnemri T, Litwack G, Alnmri ES (1995). Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res, 55, 2737-42.
20. Fernández-Alnemri T, Takahashi A, Armstrong R, et al. (1995). Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res, 55, 6045-55.
21. Frasca F, Pandini G, Sciacca L, et al. (2008). The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem, 114, 23-37.
22. Fuchs SY, Ougolkov AV, Spiegelman VS, et al. (2005). Oncogenic beta-catenin signaling networks in colorectal cancer. Cell Cycle, 4, 1522-39.
23. Gates MA, Tworoger SS, Hecht JL, et al. (2007). A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer, 121, 2225-32.
24. Gow AJ, Chen Q, Hess DT, et al. (2002). Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem, 277, 9637-40.
25. Greenlee R, Murray R, Bolden S, et al. (2000). Cancer statistics, 2000. CA Cancer J Clin, 50, 7-33.
26. Gregus Z, Fekete T, Halaszi E, et al (1996). Lipoic acid impairs glycine conjucation of benzoic acid and renal excretion of benzoglycine. Drug Metabol Dispos, 24, 682-8.
27. Guizani N, Waly MI, Singh V, et al (2013). Nabag (Zizyphus spina-christi) extract prevents aberrant crypt foci development in colons of azoxymethane-treated rats by abrogating oxidative stress and inducing apoptosis. Asian Pac J Cancer Prev, 14, 5031-5.
28. Gupta RA, DuBois RN (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer, 1, 11-21.
29. Hakomori S (1996). Tumor malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res, 56, 5309-18.
30. Halliwell B, Gutteridge JMC (1989). Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. In: Cheeseman Kh, Slater Tf, Editors. Free Radicals In Biology And Medicine. Oxford: Clarendon Press.144-7.
31. Hamiza OO, Rehman MU, Tahir M, et al. (2012). Amelioration of 1,2 dimethylhydrazine (DMH) induced colon oxidative stress, inflammation and tumor promotion response by tannic acid in Wistar rats. Asian Pac J Cancer Prev, 13, 4393-402.
32. Hanif R, Pittas A, Feng Y (1996). Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol, 52, 237-45.
33. He XQ, Cichello SA, Duan JL, et al. (2014). Canola oil influence on azoxymethane-induced colon carcinogenesis, hypertriglyceridemia and hyperglycemia in Kunming mice. Asian Pac J Cancer Prev, 15, 2477-83.
34. Hempel J, Pforte H, Raab B, et al. (1999). Flavonols and flavones of parsley cell suspension culture change the antioxidative capacity of plasma in rats. Mol Nutr Food Res, 43, 201-4.
35. Hess DT, Matsumoto A, Kim SO, et al. (2005). Protein S-nitrosylation: preview and parameters. Nat Rev Mol Cell Biol, 6, 150-66.
36. Hirayama A, Yoh K, Nagase S, et al. (2003). EPR imaging of reducing activity in Nrf2 transcriptional factor-deficient mice. Free Radic Biol Med, 34, 1236-42.
37. Holland R, Hawkins AE, Eggler AL, et al. (2008). Prospective type 1 and type 2 disulfides of Keap 1 protein. Chem Res Toxicol, 21, 2051-60.
38. Hwang JT, Park OJ, Lee YK, et al. (2011). Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-κB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med, 28, 25-31.
39. Itoh K, Chiba T, Takahashi S, et al. (1997). An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun, 236, 313-22.
40. Jung JI, Cho HI, Kim J, et al. (2008). trans-10, cis-12 conjugated linoleic acid inhibits insulin-like growth factor-I receptor signaling in TSU-Pr1 human bladder cancer cells. J Med Food, 13, 13-9.
41. Khor TO, Huang MT, Prawan A, et al. (2008). Increased susceptibility of Nrf2 knockout mice to colitis associated colorectal cancer. Cancer Prev Res, 1, 187-91.
42. Kim DY, Cho HJ, Kim J, et al. (2012). Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC Gastroenterol, 12, 9.
43. Kocic B, Kitic D, Brankovic S (2013). Dietary flavonoid intake and colorectal cancer risk: evidence from human population studies. J BUON, 18, 34-43.
44. Kumar A, Pandurangan AK, Lu F, et al. (2012). Chemopreventive sphingadienes downregulate wnt signaling via a PP2A/ Akt/GSK3β pathway in colon cancer. Carcinogenesis, 33, 1726-35.
45. LeMarchand L (2002). Cancer preventive effects of flavonoids-a review. Biomed Pharmaco, 56, 296-301.
46. Lim DY, Cho HJ, Kim J, et al. (2012). Luteolin decreases IGF-II production and downregulates insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells. BMC Gastroenterol, 12, 9.
47. Lim DY, Jeong Y, Tyner AL, et al. (2007). Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am J Physiol Gastroint Liver Physiol, 292, 66-75.
48. Madrigal-Bujaidar E, Martino Roaro L, Garcia-Aguirre K, Garcia-Medina S, Alvarez-Gonzalez I. (2013). Grapefruit juice suppresses azoxymethane-induced colon aberrant crypt formation and induces antioxidant capacity in mice. Asian Pac J Cancer Prev, 14, 6851-6.
49. Manju V, Balasubramaniyan V, Nalini N (2005). Rat colonic lipid peroxidation and antioxidant status: the effects of dietary luteolin on 1,2-dimethylhydrazine challenge. Cell Mol Biol Lett, 10, 535-51.
50. Manju V, Nalini N (2005). Chemopreventive potential of luteolin during colon carcinogenesis induced by 1,2-dimethylhydrazine. Ital J Biochem, 54, 268-75.
51. Manju V, Nalini N (2007). Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis. Cell Biochem Function, 25, 189-94.
52. McLellan EA, Medline A, Bird RP (1991). Dose responsive and proliferative characteristics of aberrant crypt foci: a putative preneolastic lesion in rat colon. Carcinogenesis, 12, 2093-8.
53. Mencherini T, Picerno P, Scesa C, et al. (2007). Triterpene, antioxidant, and antimicrobial compounds from melissa officinalis. J Nat Products, 70, 1889-94.
54. Miean KH, Mohamed S (2001). Flavonoid (myricetin, quercetin, kaempferol, luteolin, and apigenin) contentof edible tropical plants. J Agri Food Chem, 49, 3106-12.
55. Moser A, Pitot HC, Dove WF (1990). A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science, 247, 322-4.
56. Neuhouser ML (2004). Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer, 50, 1-7.
57. Nishitani Y, Yamamoto K, Yoshida M, et al. (2013). Intestinal anti-inflammatory activity of luteolin: role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells. Biofactors, 39, 522-33.
58. Pandurangan AK (2013). Potential targets for the prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev, 14, 2201-5.
59. Pandurangan AK, Esa NM (2014). Signal transducer and activator of transcription 3: a promising target in colitis associated cancer. Asian Pac J Cancer Prev, 15, 551-60.
60. Pandurangan AK, Dharmalingam P, Ananda Sadagopan SK, et al. (2013). Luteolin induces growth arrest in colon cancer cells through involvement of Wnt/β-catenin/GSK-3β signaling. J Environ Pathol Toxicol Oncol, 32, 131-9.
61. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, et al. (2013). Luteolin, a bioflavonoid attenuates azoxymethane-induced effects on mitochondrial enzymes in Balb/c mice. Asian Pac J Cancer Prev, 14, 6669-72.
62. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, et al. (2013). Inhibitory effect of luteolin on the status of membrane bound ATPases against azoxymethane-induced colorectal cancer. J Chem Pharm Res, 5, 123-7.
63. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, et al. (2014). Luteolin, a bioflavonoid inhibits azoxymethane-induced colorectal cancer through Nrf2 signaling. Toxicol Mech Methods, 24, 13-20.
64. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, et al. (2014). Inhibitory effect of luteolin on azoxymethane-induced colon carcinogenesis: involvement of iNOS and COX-2. Pharmacog Mag, 10, 306-10.
65. Pandurangan AK, Ananda Sadagopan SK, Dharmalingam P, et al. (2014). Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis. Human Exp Toxicol, (Equb Ahead of Print).
66. Pandurangan AK, Dharmalingam P, Anandasadagopan SK, et al. (2012). Effect of luteolin on the levels of glycoproteins during azoxymethane-induced colon carcinogenesis in mice. Asian Pac J Cancer Prev, 13, 1569-73.
67. Pandurangan AK, Esa NM (2013). Dietary non-nutritive factors on regulatory molecules in colorectal cancer: an update. Asian Pac J Cancer Prev, 14, 5543-52.
68. Pandurangan AK, Ganapasam S (2013a). Luteolin modulates cellular thiols on azoxymenthane-induced colon carcinogenesis. Asian J Exp Biol Sci, 4, 245-50.
69. Pandurangan AK, Ganapasam S (2013). Cytotoxic effect of luteolin on human colorectal cancer cell line (HCT-15): crucial involvement of reactive oxygen species. Middle East J Cancer, 4, 177-82.
70. Pandurangan AK, Ganapsam G (2013). Luteolin induces apoptosis in azoxymethane-induced colon carcinogenesis through involvement of Bcl-2, bax, and caspase-3. J Chem Pharm Res, 5, 143-28.
71. Pitot HC (1986). Fundamentals of Oncology: Newyork: Marcer Dekker, Inc.
72. Ramos AA, Pereira-Wilson C, Collins AR (2010). Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutat Res, 692, 6-11.
73. Rao CV, Cooma I, Simi B, et al. (2002). Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res, 62, 165-70.
74. Rao CV, Kawamori T, Hamid R, et al. (1999). Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis, 20, 641-64.
75. Ross JA, Kasum CM (2002). Dietary flavonoids: bioavailability, metabolic effects, and safety. Ann Rev Nutr, 22, 19-34.
76. Ruan JS, Liu YP, Zhang L, et al. (2012). Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition. Acta Pharmacol Sin, 33, 1325-31.
77. Salib JY, Micheal HN, Esande EF (2013). Anti-diabetic properties of flavonoid compounds isolated from hyphaenethebaicaepi carp. on alloxan induced diabetic rats. Pharmacog Res, 5, 22-9.
78. Scholz D, Horpacsy G, Mebel M (1983). Late prognosis in acute post-transplant renal failure in 102 patients. Eur Urol, 5, 14-7.
79. Selvam S, Nagini S (1995). Administration of the plasticizer di(engl hexyl)phthalate alters glycoconjugate profile. Ind J Physiol Pharmacol, 39, 252-4.
80. Sen U, Guha S, Chowdhury JR (1983). Serum fucosyl transferase activity and serum fucose levels as diagnostic tools in malignancy. Acta Med Okayama, 37, 457-62.
81. Sengupta A, Ghosh S, Das S (2002). Inhibition of cell proliferation and induction of apoptosis during azoxymethane induced colon carcinogenesis by black tea. Asian Pac J Cancer Prev, 3, 41-6.
82. Shafie NH, Esa NM, Ithnin H, et al. (2013a). Preventive Inositol hexaphosphate extracted from rice bran inhibits colorectal cancer through involvement of Wnt/β-catenin and COX-2 pathways. Bio Med Res Int, 2013, 681027.
83. Shafie NH, Esa NM, Ithnin H, et al. (2013b). Pro-apoptotic effect of rice bran inositol hexaphosphate (IP6) on HT-29 colorectal cancer cells. Int J Mol Sci, 14, 23545-58.
84. Sharma RA, Gescher A, Plastaras JP (2001). Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells. Carcinogenesis, 22, 1557-60.
85. Sheng H, Shao J, Morrow JD (1998). Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res, 58, 362-6.
86. Shimoi K, Okada H, Furugori M, et al. (1998). Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans. FEBS Lett, 438, 220-4.
87. Somchit M, Changtam C, Kimseng R, et al. (2014). Demethoxycurcumin from curcuma longa rhizome suppresses iNOS induction in an in vitro inflamed human intestinal mucosa model. Asian Pac J Cancer Prev, 15, 1807-10.
88. Sriram N, Kalayrasan S, Ashokkumar P, et al. (2008). Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-κB, and ERK. Mol Cell Biochem, 311, 157-65.
89. Summart R, Chewonarin T, (2014). Purple rice extract supplemented diet reduces DMH-induced aberrant crypt foci in the rat colon by inhibition of bacterial β-glucuronidase. Asian Pac J Cancer Prev, 15, 749-55.
90. Sun T, Xu Z, Wu CT, et al. (2007). Antioxidant activities of different colored sweet bell peppers (Capsicum annuum L). J Food Sci, 72, 98-102.
91. Swan DK, Ford B (1997). Chemoprevention of cancer: review of the literature. Oncol Nursing Forum, 24, 719-27.
92. Takahashi M, Mutoh M, Kawamori T, et al. (2000). Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis, 21, 1319-27.
93. Tammasakchai A, Reungpatthanaphong S, Chaiyasut C, et al. (2012). Red strain oryza sativa-unpolished Thai rice prevents oxidative stress and colorectal aberrant crypt foci formation in rats. Asian Pac J Cancer Prev, 13, 1929-33.
94. Tanaka T, Shimizu M, Kohno H, et al. (2001). Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from zingiber zerumbet. Life Sci, 69, 1935-45.
95. Tang X, Wang H, Fan L, et al. (2011). Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs. Free Rad Biol Med, 50, 1599-609.
96. Thun MJ, Henley SJ, Patrono C (2002). Nonsteroidal anti-inflammatory drugs as anticancer agents:mechanistic, pharmacologic, and clinical issues. J Natl Cancer Ins, 94, 252-66.
97. Tsujii M, DuBois RN (1995). Alteration in cellular adhesion and apoptosis in epithelial cells over expressing prostaglandin endoperoxide synthase 2. Cell, 83, 493-501.
98. Turini ME, DuBois RN (2002). Cyclooxygenase-2: a therapeutic target. Ann Rev Med, 53, 35-57.
99. Upsani CD, Khera A, Balaraman R (2001). Effect of Lead and vitamin E, C orspiruline on malondialdehyde, conjugated dienes and hydroperoxides in rats. Ind J Exp Biol, 39, 70-4.
100. Volate SR, Davenport DM, Muga SJ, et al. (2005). Modulation of aberrantcrypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis, 26, 450-6.
101. Waly MI, Ali A, Guizani N, et al. (2012). Pomegranate (Punicagranatum) peel extract efficacy as a dietary antioxidant against azoxymethane-induced colon cancer in rat. Asian Pac J Cancer Prev, 13, 4051-5.
102. Wang LM, Xie KP, Huo HN, et al. (2012). Luteolin inhibits proliferation induced by IGF-1 pathway dependent ERα in human breast cancer MCF-7 cells. Asian Pac J Cancer Prev, 13, 1431-7.
103. Wang TT, Wang SK, Huang GL, et al. (2012a). Luteolin induced-growth inhibition and apoptosis of human esophageal squamous carcinoma cell line Eca109 cells in vitro. Asian Pac J Cancer Prev, 13, 5455-61.
104. Wang W, Van Alstyne PC, Irons KA, et al. (2004). Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines. Nutr Cancer, 48, 106-14.
105. Willet WC, Stampfer MJ, Colditz GA, et al. (1990). Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. New Eng J Med, 323, 1664-762.
106. Xu C, Huang MT, Shen G, et al. (2006). Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res, 66, 8293-6.
107. Xu T, Li D, Jiang D (2012). Targetting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion. Nutrients, 4, 2008-19.
108. Yagihashi N, Kasajima H, Sugai S, et al. (2000). Increased in situ expression of nitric oxide synthase inhuman colorectal cancer. Virchows Arch Int J Pathol, 436, 109-14.
109. Yamamoto T, Suzuki T, Kobayashi A, et al. (2008). Physiological significance of eactive cysteine residues of Keap 1 in determining Nrf2 activity. Mol Cell Biol, 28, 2758-70.
110. Zhang DD (2006). Mechanistic studies of the Nrf2-keap1 signaling pathway. Drug Metab Rev, 38, 769-89.
111. Zhou Q, Yan B, Hu X (2009). Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin. Mol Cancer Ther, 8, 1684-91.
112. Zou H, Henzel WJ, Liu XS, et al. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90, 405-13.
113. Zou X, Liu SL, Zhou JY, et al. (2012). Beta-asarone induces LoVo colon cancer cell apoptosis by up-regulation of caspases through a mitochondrial pathway in vitro and in vivo. Asian Pac J Cancer Prev, 13, 5291-8.